OPA3
Optic atrophy 3 protein
Also known as: FLJ22187, MGA3, OPA3_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9H6K4
- Gene
- OPA3
- Ensembl
- ENSG00000125741
- Chromosome
- 19
- Canonical length
- 179 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted membrane proteins
- Subcellular location
- Nucleoplasm,Cytosol
OverviewNCBI Gene
The mouse ortholog of this protein co-purifies with the mitochondrial inner membrane. Mutations in this gene have been shown to result in 3-methylglutaconic aciduria type III and autosomal dominant optic atrophy and cataract. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2009]
Canonical amino-acid sequenceUniProt
179 residues, UniProt reviewed canonical sequence.
>Q9H6K4|OPA3
1 MVVGAFPMAK LLYLGIRQVS KPLANRIKEA ARRSEFFKTY ICLPPAQLYH WVEMRTKMRI
61 MGFRGTVIKP LNEEAAAELG AELLGEATIF IVGGGCLVLE YWRHQAQQRH KEEEQRAAWN
121 ALRDEVGHLA LALEALQAQV QAAPPQGALE ELRTELQEVR AQLCNPGRSA SHAVPASKKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against OPA3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 12 nTPM
Expression across tissuesHPA
Tissue
- tongue: 12 nTPM
- parathyroid gland: 12 nTPM
- skeletal muscle: 9.9 nTPM
- heart muscle: 9.6 nTPM
- testis: 8.4 nTPM
- kidney: 7.6 nTPM
Single-cell type
- neutrophils: 211 nCPM
- enterocytes: 126 nCPM
- cone photoreceptor cells: 75 nCPM
- breast myoepithelial cells: 72 nCPM
- renal collecting duct intercalated cells: 70 nCPM
- endometrial luminal cells: 68 nCPM
Immune cell
- non-classical monocyte: 9.2 nTPM
- NK-cell: 7.8 nTPM
- intermediate monocyte: 6.9 nTPM
- myeloid DC: 5.4 nTPM
- basophil: 5.1 nTPM
- classical monocyte: 5.1 nTPM
Brain region
- thalamus: 19 nTPM
- pons: 18 nTPM
- cerebral cortex: 18 nTPM
- medulla oblongata: 17 nTPM
- midbrain: 16 nTPM
- choroid plexus: 15 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about OPA3.
Disease | AllUniProt
Conditions OPA3 is implicated in, by any mechanism.
- 3-methylglutaconic aciduria 3 (MGCA3) MIM:258501
- Optic atrophy 3 (OPA3) MIM:165300
Disease | GeneticClinVar
38 pathogenic / likely-pathogenic of 633 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- 3-Methylglutaconic aciduria type 3
- Optic atrophy 3
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.13
- gnomAD pLI
- 0.57
- gnomAD missense Z
- 0.05
- DepMap mean gene effect
- -0.04
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- bone development
- fat cell differentiation
- mitochondrion organization
- neuromuscular process
- regulation of growth
- regulation of lipid metabolic process
- visual perception
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Optic atrophy 3-like
- Optic atrophy 3 protein (OPA3)
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads OPA3 as an antibody target. Whether an autoantibody or antibody against OPA3 could matter depends on whether native OPA3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
OPA3 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label OPA3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...